Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Y. P. Dragan"'
Autor:
R M, O'Regan, A, Cisneros, G M, England, J I, MacGregor, H D, Muenzner, V J, Assikis, M M, Bilimoria, M, Piette, Y P, Dragan, H C, Pitot, R, Chatterton, V C, Jordan
Publikováno v:
JNCI Journal of the National Cancer Institute. 90:1552-1558
Background Tamoxifen has been shown to promote the growth of human endometrial tumors implanted in athymic mice, and it has been associated with a twofold to threefold increase in endometrial cancer. Toremifene, a chlorinated derivative of tamoxifen,
Publikováno v:
Toxicological Sciences. 43:129-138
Autor:
Y. P. DRAGAN, T. RIZVI, Y-H. XU, J. R. HULLY, N. BAWA, H. A. CAMPBELL, R. R. MARONPOT, H. C. PITOT
Publikováno v:
Toxicological Sciences. 16:525-547
Autor:
Y P Dragan, F S Wolenski
Publikováno v:
Cell Death & Disease
The ability to detect and monitor potential toxicities of new clinical candidates is an absolute necessity for any pharmaceutical agent before the clinic. This safety profile is established during pre-clinical development through in vitro assays and
Publikováno v:
Molecular carcinogenesis. 28(1)
Neoplastic development is a multistep process that involves the stochastic accumulation of heritable genetic alterations in proto-oncogenes, DNA repair genes, and tumor suppressor genes. Loss of heterozygosity (LOH) analysis has been used successfull
Publikováno v:
Molecular carcinogenesis. 25(3)
An albumin-simian virus 40 (SV40) large T-antigen (T-Ag) transgenic model and a chemically induced model of multistage hepatocarcinogenesis were created in our laboratory to study the molecular mechanisms involved in the genesis and progression of ne
Publikováno v:
Cancer research. 57(16)
Hepatocytes isolated from 3-month-old female rats bearing the albumin promoter/enhancer SV40 T antigen construct as a transgene demonstrated a 20% aneuploidy rate and a significant duplication of chromosome 1. Other chromosome changes were observed b
Publikováno v:
Cancer research. 55(8)
The nonsteroidal antiestrogen tamoxifen is widely used in breast cancer treatment and is currently under evaluation as a chemopreventive agent for individuals at high risk of contracting the disease. The effects of tamoxifen administration on the exp
Autor:
H C, Pitot, Y P, Dragan
Publikováno v:
Progress in clinical and biological research. 391
Autor:
L M, Sargent, Y P, Dragan, N, Bahnub, J E, Wiley, C A, Sattler, P, Schroeder, G L, Sattler, V C, Jordan, H C, Pitot
Publikováno v:
Cancer research. 54(13)
Tamoxifen has found extensive use in the treatment of all stages of human breast cancer. The efficacy of tamoxifen treatment for the prevention of second primary tumors and its chemosuppressive action in animal models have led to initiation of clinic